Some of these might be a bit old, but I was looking through some articles (and there's alot fom around the world!) from Thailand to China, to Middle East to the UK, just Google Recell and many stories, so I for one have no issues with PR - I think its selling itself, and is snowballing!
What I hadn't realised is additional markets and collaborations for example Ulcers (mkt US $1b)...
http://www.businesswire.com/news/home/20111014005144/en/Avita-Medical-Launches-ReCell%C2%AE-Spray-On-Skin%E2%84%A2-Treatment-Venous
and also in conjunction with biological wound dressings...
http://www.businesswire.com/news/home/20110427007111/en/Study-Demonstrates-Avita-Medical%E2%80%99s-ReCell%C2%AE-Spray-On-Skin%E2%84%A2
Sorry if its old news for some, but just reminding myself that this is only just beginning and seems to be taking the medical world by storm. The fact that they've treated 3,500 cases globably and sucess stories are increasing all continue to make a compelling argument (for me) to hold and increase.
Its a special thing they are doing!
GLA
Maddoc
- Forums
- ASX - By Stock
- re:more us coverage on fda trials
Some of these might be a bit old, but I was looking through some...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.53 |
Change
0.150(6.30%) |
Mkt cap ! $172.2M |
Open | High | Low | Value | Volume |
$2.44 | $2.54 | $2.43 | $877.0K | 352.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 250 | $2.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.54 | 6577 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250 | 2.520 |
1 | 20161 | 2.510 |
1 | 594 | 2.500 |
1 | 657 | 2.470 |
1 | 75 | 2.450 |
Price($) | Vol. | No. |
---|---|---|
2.540 | 6577 | 1 |
2.550 | 6935 | 4 |
2.560 | 350 | 1 |
2.570 | 1000 | 1 |
2.590 | 3921 | 1 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |